kabutan

MEDINET Co., Ltd.(2370) Summary

2370
TSE Growth
MEDINET Co., Ltd.
28
JPY
-1
(-3.45%)
Apr 28, 3:30 pm JST
0.17
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
28.5
Apr 28, 11:47 pm JST
Summary Chart Historical News Financial Result
PER
PBR
2.27
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
29 JPY 0.18 USD
Previous Close Apr 27
29 JPY 0.18 USD
High Apr 28, 9:00 am
29 JPY 0.18 USD
Low Apr 28, 9:00 am
28 JPY 0.17 USD
Volume
399,800
Trading Value
0.01B JPY 0.07M USD
VWAP
28.49 JPY 0.18 USD
Minimum Trading Value
2,800 JPY 17 USD
Market Cap
7.77B JPY 0.05B USD
Number of Trades
82
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
Mid
1-Year Average
169
1-Year High Jun 24, 2025
1,875
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 13,161,900
Apr 17, 2026 0 12,483,400
Apr 10, 2026 0 12,230,700
Apr 3, 2026 0 12,352,600
Mar 27, 2026 0 12,339,600
Company Profile
MEDINET Co., Ltd. is a venture business originating from the Institute of Medical Science at the University of Tokyo. The company provides comprehensive services for cancer immunotherapy and is also involved in pharmaceutical development.
Sector
Services
MEDINET Co., Ltd. operates in the cell processing industry and regenerative medicine product business. In the cell processing industry, the company manufactures specific cell products for medical institutions, contracts the production of clinical and trial cell products for companies and universities, manages cell culture processing facilities, and provides dispatch and education systems for cell processing technicians. In the regenerative medicine product business, MEDINET Co., Ltd. aims to obtain manufacturing and marketing approval for regenerative medicine products through joint research with universities and other institutions.